Edan Instruments

Edan Instruments Cash Flow per Share

The Operating Cash Flow per Share of Edan Instruments (300206.SZ) as of Oct 27, 2026 is 0.61 CNY. In the previous year, Operating Cash Flow per Share was 0.64 CNY — a change of -5.03% (lower).

Cash Flow per Share

0.61CNY

YoY

-5.03%

Last updated:

Operating Cash Flow per Share of Edan Instruments is 2025 0.61 CNY. Operating Cash Flow per Share of Edan Instruments was 2024 0.64 CNY. It decreases by -5.03% lower compared to the previous year.

The Edan Instruments Cash Flow per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Flow per Share
Date
Cash Flow per Share
Jan 1, 2018
0.14 CNY
Jan 1, 2019
0.20 CNY
Jan 1, 2020
1.19 CNY
Jan 1, 2021
0.41 CNY
Jan 1, 2022
0.58 CNY
Jan 1, 2023
0.27 CNY
Jan 1, 2024
0.64 CNY
Jan 1, 2025
0.61 CNY
The Edan Instruments Cash Flow per Share history
YEARCash Flow per ShareYoY
0.61CNY-5.03%
0.64CNY+141.08%
0.27CNY-54.45%
0.58CNY+42.80%
0.41CNY-65.53%
1.19CNY+499.07%
0.20CNY+40.50%
0.14CNY-27.62%
0.19CNY-354.89%
-0.08CNY-256.95%
0.05CNY+231.22%
0.01CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Edan Instruments Stock analysis

What does Edan Instruments do? Edan Instruments, Inc. generates revenue through the design, manufacture, and sale of medical equipment, including maternity product series like doppler fetal heart beat monitors, ultrasonic doppler fetal heart beat monitors, fetal/maternal monitors, and maternity integrated diagnostic monitoring systems. The company also sells electrocardiograph series such as digital twelve-channel electrocardiographs, digital six-channel electrocardiographs, and electrocardiographic workstations, along with monitoring products like portable multi-variable monitors and central monitoring systems. Additionally, Edan offers spare parts and in vitro diagnostics products to support its equipment and medical services. The primary buyers of Edan's products are healthcare institutions, including hospitals and clinics, which purchase medical devices for diagnostic and monitoring purposes. These institutions rely on Edan's maternity, electrocardiograph, and monitoring systems to provide patient care. The company's in vitro diagnostics products are also sold to medical facilities for laboratory testing needs. Edan's product segments are defined by medical equipment categories: maternity, electrocardiograph, monitoring, and ultrasonic image systems. The spare parts and in vitro diagnostics businesses complement these segments by providing essential accessories and diagnostic tools. Revenue is derived from direct sales of these products to healthcare providers, with no mention of third-party distribution or additional services beyond the described offerings. Edan Instruments is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Edan Instruments stock

Operating Cash Flow per Share of Edan Instruments is 0.61 CNY in 2025.

Operating Cash Flow per Share of Edan Instruments changed from 0.64 CNY to 0.61 CNY, representing a -5.03% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow per Share Edan Instruments since 2006 – with annual values, charts, and detailed analysis.

Operating cash flow per share measures the operating cash generated per outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Edan Instruments

All Key Metrics — Edan Instruments